Is Thrombin Time useful for the assessment of dabigatran concentrations? An in vitro and ex vivo study
- 1 September 2015
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 136 (3) , 693-696
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Estimation of dabigatran plasma concentrations in the perioperative settingThrombosis and Haemostasis, 2015
- Laboratory Measurement of the Anticoagulant Activity of the Non–Vitamin K Oral AnticoagulantsJACC, 2014
- Dabigatran assessment in patients with acute complications using routine coagulation assaysBlood Coagulation & Fibrinolysis, 2014
- Measuring Dabigatran Concentrations Using a Chromogenic Ecarin Clotting Time AssayAnnals of Pharmacotherapy, 2013
- Evaluation of coagulation assays versus LC-MS/MS for determinations of dabigatran concentrations in plasmaEuropean Journal of Clinical Pharmacology, 2013
- Performance of coagulation tests in patients on therapeutic doses of dabigatran: a cross‐sectional pharmacodynamic study based on peak and trough plasma levelsJournal of Thrombosis and Haemostasis, 2013
- The effect of dabigatran on the activated partial thromboplastin time and thrombin time as determined by the Hemoclot thrombin inhibitor assay in patient plasma samplesThrombosis and Haemostasis, 2013
- Comparison of calibrated dilute thrombin time and aPTT tests with LC-MS/MS for the therapeutic monitoring of patients treated with dabigatran etexilateThrombosis and Haemostasis, 2013
- Impact of dabigatran on a large panel of routine or specific coagulation assaysThrombosis and Haemostasis, 2012
- Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activityThrombosis and Haemostasis, 2010